Evidence map›Paper›PMID 41596209›Full record

ArticleInternational journal of molecular sciences2026

Very-Low-Density Lipoproteins Quantity but Not Composition Is Altered in Normotriglyceridemic Subjects with Elevated Lipoprotein (a) Level.

Ewa Wieczorek-Breitzke, Martyna Feliksiak, Agnieszka Kuchta, Maciej Jankowski, Agnieszka Ćwiklińska

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Ewa Wieczorek-BreitzkeDepartment of Clinical Chemistry, Faculty of Pharmacy, Medical University of Gdańsk, 80-211 Gdansk, Poland.ORCID 0000-0002-7872-4725
Martyna FeliksiakCentral Clinical Laboratory, University Clinical Centre in Gdańsk, 80-952 Gdansk, Poland.
Agnieszka KuchtaDepartment of Clinical Chemistry, Faculty of Pharmacy, Medical University of Gdańsk, 80-211 Gdansk, Poland.ORCID 0000-0003-2264-1442
Maciej JankowskiDepartment of Clinical Chemistry, Faculty of Pharmacy, Medical University of Gdańsk, 80-211 Gdansk, Poland.ORCID 0000-0003-4540-6955
Agnieszka ĆwiklińskaDepartment of Clinical Chemistry, Faculty of Pharmacy, Medical University of Gdańsk, 80-211 Gdansk, Poland.ORCID 0000-0003-1426-3744

Funding

Gdańsk Medical University Financial support program for the scientific development of young researchers at the Medical University of Gdańsk - 01-65023/0005603 (budget no. 643)
6 · The paper itself

Abstract

Cardiovascular disease (CVD) is influenced by disturbances in lipoprotein composition and metabolism, including triglyceride-rich lipoproteins (TRLs) and elevated lipoprotein (a) (Lp(a)). While interactions between Lp(a) and very-low-density lipoproteins (VLDL) have been studied in hypertriglyceridemic and CVD populations, data in normotriglyceridemic individuals without CV events are limited. Seventy normotriglyceridemic adults with triglycerides < 150 mg/dL and no CV events were enrolled and divided into two groups based on Lp(a) concentration: <30 mg/dL and ≥30 mg/dL. VLDL was isolated by ultracentrifugation, and concentrations of Lp(a), lipids (triglycerides, cholesterol), and apolipoproteins (apo B, apo C-II, apo C-III, apo E) were measured in serum and VLDL. Serum lipid and apolipoprotein concentrations did not differ between the groups. Individuals with Lp(a) ≥ 30 mg/dL had significantly higher VLDL concentrations of triglycerides (+71%), cholesterol (+54%), apo B (+28%), apo C-II (+36%), and apo C-III (+33%). Ratios of lipids and apolipoproteins to apo B indicated unchanged VLDL particle composition, suggesting that differences reflected increased particle number rather than altered composition. In normotriglyceridemic subjects with Lp(a) ≥ 30 mg/dL, VLDL particles are more abundant but compositionally unchanged. Redistribution of lipids and apolipoproteins toward VLDL may contribute to VLDL residual cardiovascular risk, underscoring the need for further studies on VLDL-Lp(a) interactions.

Indexed as

Lipoprotein(a)Lipoproteins, VLDLTriglyceridesAdultApolipoproteinsCardiovascular DiseasesCholesterolFemaleHumansMaleMiddle AgedApolipoproteinsCholesterolLipoprotein(a)Lipoproteins, VLDLTriglyceridesapolipoproteinslipoprotein (a)normotriglyceridemiatriglyceridesvery-low-density lipoproteins

Identifiers

PMID41596209
PMCPMC12841498

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.